Autoimmune Diseases
4 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Immune System Diseases
Narrower: Antiphospholipid Syndrome 1, Immunoglobulin G4-Related Disease 1
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Belimumab+SOC for antiphospholipid syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Biospecimen Collection + Nasal Swab + Survey Administration + REMDESIVIR for autoimmune diseases | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Efgartigimod alfa for immunoglobulin g4-related disease | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| fetal MSCs combined with 4SCAR T cells for autoimmune diseases | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.